Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis

Fig. 1

Global proteome characterization of LUAD and healthy plasma a The protocol of detailing experiments b Identification of quantifiable proteins from MS/MS spectra c Principal Component Analysis of quantified proteins, a complete separation of LUAD and NL groups d Pearson’s Correlation Coefficient of LUAD and NL groups. e volcano plot of all proteins in LUAD compared to NL

Back to article page